New and Generic Drug Approvals
March 19, 2014
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Diamox | acetazolamide | Capsule, Extended Release;Oral | Duramed Pharms Barr | Manufacturing Change or Addition |
| Gallium Citrate Ga 67 | gallium citrate ga-67 | Injectable;Injection | Mallinckrodt | Manufacturing Change or Addition |
| Impavido | miltefosine | Capsule;Oral | Paladin Therapeutics Inc | Approval |
| Multaq | dronedarone hydrochloride | Tablet;Oral | Sanofi Aventis Us | Labeling Revision |
| Multaq | dronedarone hydrochloride | Tablet;Oral | Sanofi Aventis Us | Manufacturing Change or Addition |
| Neuraceq | florbetaben | Injectable; Injection | Piramal Imaging | Approval |
| Penicillin G Potassium In Plastic Container | penicillin g potassium | Injectable;Injection | Baxter Hlthcare | Manufacturing Change or Addition |
| Perforomist | formoterol fumarate | Solution;Inhalation | Mylan Speclt | Manufacturing Change or Addition |
| Prograf | tacrolimus | Capsule;Oral | Astellas | Manufacturing Change or Addition |
| Qnasl | beclomethasone dipropionate | Aerosol, Metered;Nasal | Teva Branded Pharm | Labeling Revision |
| Sirturo | bedaquiline fumarate | Tablet;Oral | Janssen Therap | Manufacturing Change or Addition |
| Sodium Polystyrene Sulfonate | sodium polystyrene sulfonate | Powder;Oral, Rectal | Epic Pharma Llc | Approval |
| Zelboraf | vemurafenib | Tablet;Oral | Hoffmann La Roche | Efficacy Supplement with Clinical Data to Support |
Para más información de nuestros productos y servicios, visite:
Comentarios
Publicar un comentario